Literature DB >> 20584648

[Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].

Xia Li1, Gan Huang, Xiang Yan, Lin Yang, Zhi-guang Zhou.   

Abstract

OBJECTIVE: To investigate the relation between insulin resistance and glutamic acid decarboxylase antibody (GAD-Ab) titers in latent autoimmune diabetes in adults (LADA).
METHODS: The patients with phenotypic type 2 diabetes were screened for GAD-Ab positivity, and the 141 positive patients were divided into two subgroups according to the GAD-Ab titer, namely the high-titer group (LADA-1 subtype) and low-titer group (LADA-2 subgroup). The clinical features and insulin resistance were compared between the two groups. Insulin resistance was calculated by HOMA 2 software, and GAD-Ab and C peptide were determined with radioligand and radioimmune assay, respectively.
RESULTS: Compared with low-titer LADA patients, the patients with high titers had younger age of onset, lower BMI, higher HbA1c level, and worse fasting and postprandial C peptide levels. The insulin resistance index by HOMA 2 was significantly lower in LADA-1 group than in LADA-2 group (1.6-/+1.1 vs 2.1-/+1.1, P=0.001). The HOMA2-IR index showed a negative correlation to GAD-Ab titer.
CONCLUSION: The degree of insulin resistance is correlated to GAD-Ab titers in LADA, and low titer patients have higher insulin resistance level.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584648

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

Review 1.  Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.

Authors:  Yu Liao; Yufei Xiang; Zhiguang Zhou
Journal:  Front Med       Date:  2012-07-28       Impact factor: 4.592

2.  Diabetes-related autoantibodies in diabetic gastroparesis.

Authors:  Rohin Singla; Carol Homko; Ron Schey; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2015-05-09       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.